Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Kala Pharmaceuticals, Inc. | Director | Common Stock | 2.88M | $19.4M | $6.74 | Jun 17, 2021 | By Longitude Venture Partners II, L.P. |
Kala Pharmaceuticals, Inc. | Director | Common Stock | 2.53M | $17.1M | $6.74 | Jun 17, 2021 | By Longitude Venture Partners IV, L.P. |
Kala Pharmaceuticals, Inc. | Director | Common Stock | 40K | $270K | $6.74 | Jun 17, 2021 | Direct |
89bio, Inc. | Director, 10%+ Owner | Stock Option (Right to Buy) | 27.4K | Feb 9, 2023 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
ETNB | 89bio, Inc. | Feb 9, 2023 | 1 | $0 | 4 | Feb 13, 2023 | Director, 10%+ Owner |
ETNB | 89bio, Inc. | May 16, 2022 | 1 | $0 | 4 | May 18, 2022 | Director |
KALA | Kala Pharmaceuticals, Inc. | Jun 17, 2021 | 1 | $0 | 4 | Jun 21, 2021 | Director |